GHRH analogue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Light therapy is used to treat cases of neonatal jaundice. Bilirubin, a yellow pigment normally formed in the liver during the breakdown of old red blood cells, cannot always be effectively cleared by a neonate's liver causing neonatal jaundice. Accumulation of excess bilirubin can cause central nervous system damage, and so this buildup of bilirubin must be treated. Phototherapy uses the energy from light to isomerize the bilirubin and consequently transform it into compounds that the newborn can excrete via urine and stools. Bilirubin is most successful absorbing light in the blue region of the visible light spectrum, which falls between 460 and 490 nm. Therefore, light therapy technologies that utilize these blue wavelengths are the most successful at isomerizing bilirubin.
Before beginning the process of restoration of a herbarium sheet, best practices suggest that the original mounted specimen be photographed for reference to ensure a new sheet is as close to the original as possible. The original mounting sheet can be dried and flattened in the same manner as the plant to serve as a reference for positioning the specimen on a new sheet. Additionally, any labels or supplement information accompanying the plant should be placed in the same place.
21 December Figures show that UK government borrowing fell in November to £14.3bn, which was above forecasts of £13bn. Mrs Justice Yip, who presided over the trial of the two teenagers who killed Brianna Ghey, confirms she will lift the anonymity order protecting their identities when they are sentenced in February 2024. Following a three-week trial at the Old Bailey, Joshua Jacques is found guilty of the April 2022 murder of his girlfriend, Samantha Drummonds, and three members of her family in Bermondsey, south London. Eurostar is forced to cancel a number of services following a last-minute strike by staff at the Channel Tunnel operator, Getlink. Eurostar urges its customers not to travel as a result of the strike. A woman is arrested on suspicion of murder after a four-year-old boy dies from knife injuries in Hackney, east London. A yellow weather warning is in place as the UK is hit by high winds as a result of Storm Pia. 22 December Revised figures show that UK GDP contracted by 0.1% between July and October 2023, having previously shown zero growth for the period, and presenting the risk of a recession. Greater Manchester Police announce they have launched a criminal investigation into the alleged child abduction of teenager Alex Batty. Following his conviction at Birmingham Crown Court in September, student Mohamad Al Bared, of Coventry, is sentenced to life imprisonment with a minimum of 20 years for building a drone that was intended for use in a chemical weapons attack on behalf of Islamic State.
This is a promising and newer microarray application for the diagnosis, study and treatment of complex diseases such as cancer. The technology merges laser capture microdissection (LCM) with micro array technology, to produce reverse-phase protein microarrays. In this type of microarrays, the whole collection of protein themselves are immobilized with the intent of capturing various stages of disease within an individual patient. When used with LCM, reverse phase arrays can monitor the fluctuating state of proteome among different cell population within a small area of human tissue. This is useful for profiling the status of cellular signaling molecules, among a cross-section of tissue that includes both normal and cancerous cells. This approach is useful in monitoring the status of key factors in normal prostate epithelium and invasive prostate cancer tissues. LCM then dissects these tissue and protein lysates were arrayed onto nitrocellulose slides, which were probed with specific antibodies. This method can track all kinds of molecular events and can compare diseased and healthy tissues within the same patient enabling the development of treatment strategies and diagnosis. The ability to acquire proteomics snapshots of neighboring cell populations, using reverse-phase microarrays in conjunction with LCM has a number of applications beyond the study of tumors. The approach can provide insights into normal physiology and pathology of all the tissues and is invaluable for characterizing developmental processes and anomalies.
Sources: en.wikipedia.org
The genus Ambrosiella shares at least two nonribosomal peptide synthesis gene clusters with the rest of Ceratocystidaceae encoding intracellular and extracellular siderophores. These products generally help chelate or bind iron for various cellular processes and can be major virulence factors in other fungi; however, seeing as Ambrosiella do not act as serious plant pathogens, the exact role of these peptide products in mediating their relationship with live or decaying tissue has yet to be determined. Unlike serious disease-causing fungi within the Ceratocystidaceae, Ambrosiella possess only half of the full complement of catechol dioxygenases common to this family. These enzymes are generally needed to help fungi metabolize certain plant chemical defenses, and the loss of these genes may reflect this genus's association with individuals that are already weakened or dead and thus less likely to be producing effective antifungal metabolites.
Bruck syndrome is characterized as the combination of arthrogryposis multiplex congenita and osteogenesis imperfecta. Both diseases are uncommon, but concurrence is extremely rare which makes Bruck syndrome very difficult to research. Bruck syndrome is thought to be an atypical variant of osteogenesis imperfecta most resembling type III, if not its own disease. Multiple gene mutations associated with osteogenesis imperfecta are not seen in Bruck syndrome. Many affected individuals are within the same family, and pedigree data supports that the disease is acquired through autosomal recessive inheritance. Bruck syndrome has features of congenital contractures, bone fragility, recurring bone fractures, flexion joint and limb deformities, pterygia, short body height, and progressive kyphoscoliosis. Individuals encounter restricted mobility and pulmonary function. A reduction in bone mineral content and larger hydroxyapatite crystals are also detectable Joint contractures are primarily bilateral and symmetrical, and most prone to ankles. Bruck syndrome has no effect on intelligence, vision, or hearing.
They can sedate patients receiving mechanical ventilation or those in extreme distress. Caution is exercised in this situation due to the risk of respiratory depression, and it is recommended that benzodiazepine overdose treatment facilities should be available. They have also been found to increase the likelihood of later PTSD after people have been removed from ventilators. Benzodiazepines are indicated in the management of breathlessness (shortness of breath) in advanced diseases, in particular where other treatments have failed to adequately control symptoms. Benzodiazepines are effective as medication given a couple of hours before surgery to relieve anxiety. They also produce amnesia, which can be useful, as patients may not remember unpleasantness from the procedure. They are also used in patients with dental phobia as well as some ophthalmic procedures like refractive surgery; although such use is controversial and only recommended for those who are very anxious. Midazolam is the most commonly prescribed for this use because of its strong sedative actions and fast recovery time, as well as its water solubility, which reduces pain upon injection. Diazepam and lorazepam are sometimes used. Lorazepam has particularly marked amnesic properties that may make it more effective when amnesia is the desired effect. Benzodiazepines are well known for their strong muscle-relaxing properties and can be useful in the treatment of muscle spasms, although tolerance often develops to their muscle-relaxant effects.
Pregnancy: MMR vaccine and its components should not be given to pregnant women. Women of childbearing age should check with their doctor about getting vaccinated prior to getting pregnant. HIV-infected children, who may receive measles vaccines if their CD4+ lymphocyte count is greater than 15%. Weakened immune system due to HIV/AIDS or certain medical treatments Having a parent or sibling with a history of immune problems Condition that makes a patient bruise or bleed easily Recent transfusion of blood or blood products Tuberculosis Receiving other vaccines in the past 4 weeks Moderate or severe illness. However, mild illness (e.g., common cold) is usually not contraindicated.
Another measure that made him detested by the indigenous people were the appraisals made in the midst of the war chaos, without control and many times by officials who were members of the Criollo aristocracy or bought by it, which allowed the individual division of their communal lands and their purchase by the landowners, in addition to restoring indigenous tributes, mitas, and pongueajes to help Peruvian finances. Likewise, he restored slavery to blacks, pardos and mulattos (which had been abolished by San Martín) for the benefit of sugar plantations on the coast. Lastly, the old colonial cabildos were abolished. It can also be shown that he would have carried out massive repressions against opponents who had his dictatorship in Peru, such as Juan de Berindoaga y Palomares (who was shot) or Francisco Xavier de Luna Pizarro (who would be deported). Sucre would have commented on several occasions to the Liberator that so many tributes were deceptive, and that many of the Peruvian elite wanted Bolívar's failure to run to negotiate with the royalists. The Bolivarian regime quickly earned the animosity of Peruvians: Bolívar created a Supreme Court that imprisoned or exiled various political opponents, and shot patriotic soldiers or guerrillas who publicly disagreed. The exercise of freedom of the press was prevented and the right to elect their municipal authorities was withdrawn from the councils (May 26, 1826). Over time the Colombian army was seen as the Praetorian Guards of its puppet governments.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.